<DOC>
<DOCNO>
EP-0010830
</DOCNO>
<TEXT>
<DATE>
19800514
</DATE>
<IPC-CLASSIFICATIONS>
C07K-5/062 C07K-5/083 C07K-5/00 C07K-5/097 C07K-5/103 C07K-1/113 C07C-231/00 C07K-5/078 C07K-7/04 C07K-1/00 C07K-7/00 C07D-263/42 C07K-1/02 C07D-263/00 C07K-5/117 C07C-67/00 C07C-231/10 
</IPC-CLASSIFICATIONS>
<TITLE>
process for preparing unsaturated azlactones and compounds thus obtained; conversion of unsaturated azlactones to dehydropeptides and peptides thus obtained
</TITLE>
<APPLICANT>
research corpus  <sep>research corporation<sep>research corporation405 lexington avenuenew york, n.y. 10017us<sep>
</APPLICANT>
<INVENTOR>
stammer charles hughus<sep>stammer, charles hugh<sep>stammer, charles hugh718 riverhill driveathens georgia 30303us<sep>
</INVENTOR>
<ABSTRACT>
preparation of azlactones represented by the formula <chem> wherein r is a substituted or unsubstituted alkyl, aryl or nitrogen containing heterocyclic group, and r<1> is an n-blocked amino acid residue or peptide chain, and stereoisomers thereof, by oxidizing the corresponding, saturated azlactone with a benzoquinone oxidizing agent in the presence of a base.  the unsaturated azlactones, some of which are novel, can be converted to dehydropeptides, which are useful as intermediates for preparing novel biologically active compounds, or themselves have biological activity. 
</ABSTRACT>
</TEXT>
</DOC>
